Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required). This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years. [Posted on 1/15/2023. Expires on 1/14/2026]

NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Facilitates the transition of mentored, postdoctoral researchers to tenure-track or equivalent faculty positions conducting research relevant to NIA’s mission. Does not provide postdoctoral phase funding; candidates should be prepared to transition to tenure-track or equivalent faculty positions within 12 months after confirmed positive funding decision. Following transition, the award provides 3y protected research time through salary and research support. [Posted on 2/13/2024. Expires on 7/13/2026]